Reagene Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.10 Cr
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -76.85%
- Profit Growth -597.35%
- Ebitda -620.76%
- Net Worth -63.34%
- Total Assets -22.06%
About Reagene Biosciences
Reagene Biosciences Private Limited (RBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 September 2016 (Eight years and five months 2 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nishant Dhamnekar and Prema Kolachana serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24299KA2016PTC096198
-
Company No.
096198
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Sep 2016
-
Date of AGM
25 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Reagene Biosciences Private Limited offer?
Reagene Biosciences Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Chemical Test Kits, Graduation & High Education Programs, Medical Educational Service, Ammonium Compound, Medical Laboratory Instruments, Clinical Reagents, Instrument Calibration & Adjustment, Calibration Services, Bio Chemicals.
Who are the key members and board of directors at Reagene Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prema Kolachana
|
Managing Director | 01-Sep-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishant Dhamnekar
|
Director | 10-Apr-2019 | Current |
Financial Performance of Reagene Biosciences.
Reagene Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 76.85% decrease. The company also saw a substantial fall in profitability, with a 597.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reagene Biosciences?
In 2022, Reagene Biosciences had a public holding of 59.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sherlock's Pub Nagarbhavi By Cvs LlpNishant Dhamnekar and Prema Kolachana are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reagene Biosciences?
Unlock and access historical data on people associated with Reagene Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reagene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reagene Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
